Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA.
Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Science. 2022 Feb 4;375(6580):eabj4008. doi: 10.1126/science.abj4008.
Regulation of cytokine production in stimulated T cells can be disrupted in autoimmunity, immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine regulators requires both loss-of-function and gain-of-function studies, which have been challenging in primary human cells. We now report genome-wide CRISPR activation (CRISPRa) and interference (CRISPRi) screens in primary human T cells to identify gene networks controlling interleukin-2 (IL-2) and interferon-γ (IFN-γ) production. Arrayed CRISPRa confirmed key hits and enabled multiplexed secretome characterization, revealing reshaped cytokine responses. Coupling CRISPRa screening with single-cell RNA sequencing enabled deep molecular characterization of screen hits, revealing how perturbations tuned T cell activation and promoted cell states characterized by distinct cytokine expression profiles. These screens reveal genes that reprogram critical immune cell functions, which could inform the design of immunotherapies.
在自身免疫、免疫缺陷和癌症中,刺激 T 细胞产生细胞因子的调节可能会被打乱。系统地发现依赖于刺激的细胞因子调节剂需要进行功能丧失和功能获得研究,这在原代人细胞中具有挑战性。我们现在报告了在原代人 T 细胞中进行的全基因组 CRISPR 激活 (CRISPRa) 和干扰 (CRISPRi) 筛选,以鉴定控制白细胞介素-2 (IL-2) 和干扰素-γ (IFN-γ) 产生的基因网络。排列的 CRISPRa 证实了关键的命中,并实现了多路分泌组学特征,揭示了重塑的细胞因子反应。将 CRISPRa 筛选与单细胞 RNA 测序相结合,能够深入分子表征筛选命中,揭示了扰动如何调整 T 细胞激活并促进以不同细胞因子表达谱为特征的细胞状态。这些筛选揭示了可重新编程关键免疫细胞功能的基因,这可能为免疫疗法的设计提供信息。
Cell Immunol. 1994-12
J Interferon Cytokine Res. 2000-10
Trends Cancer. 2025-8-28
Nat Biotechnol. 2020-3-30
Nature. 2019-12-4
J Cell Sci. 2019-9-4
Nat Commun. 2019-4-23